Literature DB >> 20180230

Surgical treatment for liver cancer.

Nicole C Tsim1, Adam E Frampton, Nagy A Habib, Long R Jiao.   

Abstract

Primary liver cancer is amongst the commonest tumors worldwide, particularly in parts of the developing world, and is increasing in incidence. Over the past three decades, surgical hepatic resection has evolved from a high risk, resource intensive procedure with limited application, to a safe and commonly performed operation with a range of indications. This article reviews the approach to surgical resection for malignancies such as hepatocellular cancer, metastatic liver deposits and neuroendocrine tumors. Survival data after resection is also reviewed, as well as indications for curative resection.

Entities:  

Mesh:

Year:  2010        PMID: 20180230      PMCID: PMC2828596          DOI: 10.3748/wjg.v16.i8.927

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  61 in total

1.  Hepatic resection for large hepatocellular carcinoma.

Authors:  K Hanazaki; S Kajikawa; N Shimozawa; K Shimada; M Hiraguri; N Koide; W Adachi; J Amano
Journal:  Am J Surg       Date:  2001-04       Impact factor: 2.565

2.  Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease (Br J Surg 2009; 96: 175-184).

Authors:  J A Søreide
Journal:  Br J Surg       Date:  2009-07       Impact factor: 6.939

3.  Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal.

Authors:  R T Poon; S T Fan; I O Ng; J Wong
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

4.  Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation.

Authors:  Ronnie Tung-Ping Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; John Wong
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

5.  Preoperative predictors of survival after resection of small hepatocellular carcinomas.

Authors:  Jeffrey D Wayne; Gregory Y Lauwers; Iwao Ikai; Dorota A Doherty; Jacques Belghiti; Yoshio Yamaoka; Jean-Marc Regimbeau; David M Nagorney; Kim-Anh Do; Lee M Ellis; Steven A Curley; Raphael E Pollock; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

6.  Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value.

Authors:  G L Grazi; G Ercolani; F Pierangeli; M Del Gaudio; M Cescon; A Cavallari; A Mazziotti
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

7.  Resection of hepatocellular carcinoma: a European experience on 328 cases.

Authors:  J Belghiti; J M Regimbeau; F Durand; A R Kianmanesh; F Dondero; B Terris; A Sauvanet; O Farges; F Degos
Journal:  Hepatogastroenterology       Date:  2002 Jan-Feb

8.  Is surgery for large hepatocellular carcinoma justified?

Authors:  J M Régimbeau; O Farges; B Y Shen; A Sauvanet; J Belghiti
Journal:  J Hepatol       Date:  1999-12       Impact factor: 25.083

9.  Simplified staging for hepatocellular carcinoma.

Authors:  Jean-Nicolas Vauthey; Gregory Y Lauwers; Nestor F Esnaola; Kim-Anh Do; Jacques Belghiti; Nadeem Mirza; Steven A Curley; Lee M Ellis; Jean-Marc Regimbeau; Asif Rashid; Karen R Cleary; David M Nagorney
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

Review 10.  A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases.

Authors:  Axel Stang; Roman Fischbach; Wolfgang Teichmann; Carsten Bokemeyer; Dietrich Braumann
Journal:  Eur J Cancer       Date:  2009-04-06       Impact factor: 9.162

View more
  17 in total

1.  Impaired hepatocellular regeneration in murine sepsis is dependent on regulatory protein levels.

Authors:  Arnoley Abcejo; Kenneth M Andrejko; E Andrew Ochroch; Nichelle R Raj; Clifford S Deutschman
Journal:  Shock       Date:  2011-11       Impact factor: 3.454

2.  Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe?

Authors:  Russell E Brown; Matthew R Bower; Tiffany L Metzger; Charles R Scoggins; Kelly M McMasters; Michael J Hahl; Cliff Tatum; Robert C G Martin
Journal:  HPB (Oxford)       Date:  2010-12-22       Impact factor: 3.647

3.  Radiofrequency ablation of hepatocellular carcinoma: Current status.

Authors:  Yasunori Minami; Masatoshi Kudo
Journal:  World J Radiol       Date:  2010-11-28

4.  Image-guided microwave ablation of hepatic tumours: preliminary experience.

Authors:  A Veltri; C Gazzera; C Rotondella; F Camerano; M Busso; G Gandini
Journal:  Radiol Med       Date:  2011-11-17       Impact factor: 3.469

5.  Trends and Projections in National United States Health Care Spending for Gastrointestinal Malignancies (1996-2030).

Authors:  Igor Stukalin; Newaz Shubidito Ahmed; Adam M Fundytus; Alexander S Qian; Stephanie Coward; Gilaad G Kaplan; Robert J Hilsden; Kelly W Burak; Jeffrey K Lee; Siddharth Singh; Christopher Ma
Journal:  Gastroenterology       Date:  2021-12-16       Impact factor: 22.682

Review 6.  Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives.

Authors:  Li Ma; Mei-Sze Chua; Ourania Andrisani; Samuel So
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

7.  Influence of adriamycin on changes in Nanog, Oct-4, Sox2, ARID1 and Wnt5b expression in liver cancer stem cells.

Authors:  Ding Sun; Lei Qin; Yang Xu; Jian-Xia Liu; Li-Ping Tian; Hai-Xin Qian
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

8.  Liver resection for HCC outside the BCLC criteria.

Authors:  Manish S Bhandare; Shraddha Patkar; Nitin Shetty; Ashwin Polnaya; Suyash Kulkarni; Rohit R Dusane; Shailesh V Shrikhande; Mahesh Goel
Journal:  Langenbecks Arch Surg       Date:  2017-12-04       Impact factor: 3.445

9.  Effect of bile absorption coefficients on the estimation of liver tissue optical properties and related implications in discriminating healthy and tumorous samples.

Authors:  Rami Nachabé; Daniel J Evers; Benno H W Hendriks; Gerald W Lucassen; Marjolein van der Voort; Jelle Wesseling; Theo J M Ruers
Journal:  Biomed Opt Express       Date:  2011-02-15       Impact factor: 3.732

10.  Irinotecan Plus S-1 Followed by Hepatectomy for a Patient with Initially Unresectable Colorectal Liver Metastases, Who Showed Severe Drug Rash with Oxaliplatin Plus 5-FU and Leucovorin (FOLFOX).

Authors:  Hiroyuki Komori; Toru Beppu; Yasuo Sakamoto; Yuji Miyamoto; Hiromitsu Hayashi; Katsunori Imai; Hidetoshi Nitta; Masayuki Watanabe; Hideo Baba
Journal:  Case Rep Gastrointest Med       Date:  2014-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.